Related Experiment Video
Updated: May 9, 2025
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
The Practical Side Effects Experienced in Patients Treated With Medications Approved for Melanoma
Background:
Melanoma continues to remain one of the most feared malignancies among patients and dermatologists. Significant strides have been made in expanding the treatment arsenal with systemic medications and immunotherapeutics. With many more drugs available, side effects remain an important component of constructing treatment plans. Using the Food and Drug Administration (FDA) Adverse Events Reporting System (FAERS), cases of real-world side effects reported with melanoma medications were assessed to capture practical patient experiences. Treatments with the highest counts of adverse events were ipilimumab, nivolumab, dabrafenib, and vemurafenib. Individuals reported pyrexia (12.9%), rash (9.8%), diarrhea (9.5%), fatigue (7.0%), and colitis (6.7%) most frequently. Males were more likely to experience pyrexia (aOR 1.1, P=0.006), nausea (aOR 1.4, P<0.001), rash (aOR 1.3, P<0.001), vomiting (aOR 1.2, P=0.005), and headache (aOR 1.3, P<0.001). Females had higher odds of fatigue (aOR 1.2, P=0.002), decreased appetite (aOR 1.2, P=0.004), and dyspnea (aOR 1.3, P<0.001). Patients 62 years old or younger had higher odds of pyrexia (aOR 1.4, P<0.001), nausea (aOR 1.2, P=0.001), vomiting (aOR 1.3, P<0.001), and headache (aOR 2.9, P<0.001). Individuals older than 62 were more likely to report diarrhea (aOR 1.2, P<0.001), fatigue (aOR 1.4, P<0.001), and decreased appetite (aOR 1.5, P<0.001). With patients who have to already digest a difficult diagnosis, the ability to counsel individuals based on the practical side effects of treatments can pave the way for better dialogue and more trust.
Citation:
Ravipati A, Pradeep T, Jean-Pierre P, et al. The practical side effects experienced in patients treated with medications approved for melanoma. J Drugs Dermatol. 2025;24(5):539-542. doi:10.36849/JDD.8368.
Insights
This study analyzed real-world melanoma medication side effects using FDA data. Common adverse events include pyrexia, rash, and fatigue, with varying risks based on patient demographics.
Area of Science:
- Dermatology
- Oncology
- Pharmacovigilance
Background:
- Melanoma remains a significant health concern, necessitating effective treatments.
- Advances in systemic medications and immunotherapeutics have expanded melanoma treatment options.
- Understanding treatment side effects is crucial for patient management and adherence.
Purpose of the Study:
- To analyze real-world adverse events associated with melanoma medications.
- To identify the most frequently reported side effects and treatments.
- To investigate demographic variations in side effect profiles.
Main Methods:
- Utilized the Food and Drug Administration (FDA) Adverse Events Reporting System (FAERS) database.
- Assessed reported cases of side effects linked to melanoma medications.
- Analyzed frequency and demographic associations of adverse events.
Main Results:
- Ipilimumab, nivolumab, dabrafenib, and vemurafenib showed the highest adverse event counts.
- Most frequent side effects were pyrexia, rash, diarrhea, fatigue, and colitis.
- Demographic analysis revealed distinct side effect patterns in males, females, and different age groups.
Conclusions:
- Real-world data from FAERS provides valuable insights into melanoma medication side effects.
- Identifying common and demographically specific adverse events aids in patient counseling.
- Enhanced understanding of side effects can improve patient-physician dialogue and treatment trust.
Related Concept Videos
01:30Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:27Tumor Immunotherapy
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...